-
Mashup Score: 0Collaboration aims to make flotufolastat F 18 available in China for prostate cancer imaging - 2 year(s) ago
Urology Times is the leading resource for urologists & allied health professionals offering clinical analysis, policy perspectives, & practical advice.
Source: www.urologytimes.comCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 1
Investigators report findings from 14,324 adult participants in NHANES 2009 to 2018.
Source: www.renalandurologynews.comCategories: Latest Headlines, UrologyTweet-
Men who use marijuana regularly are less likely to report having #kidney stones. https://t.co/c6c7nCVJz5
-
-
Mashup Score: 3Male Infertility - 2 year(s) ago
We discuss what a patient can expect when visiting a reproductive urologist for the first time and more.
Source: my.clevelandclinic.orgCategories: Latest Headlines, UrologyTweet-
.@ScottLundyMDPhD & @SarahLacyC join the Ob/Gyn Time podcast to discuss what to expect when visiting a reproductive urologist, including when to seek help & the types of testing that may be involved. Podcast| Male Infertility https://t.co/mX8oDyrOgK via @clevelandclinic
-
-
Mashup Score: 0Kidney Transplant Waitlisting Disparities Affect Even Younger, Healthier Patients - Renal and Urology News - 2 year(s) ago
Study findings suggest kidney transplant waitlist disparities are not due to differences in comorbidity burden across populations.
Source: www.renalandurologynews.comCategories: Latest Headlines, UrologyTweet-
Waitlist disparities even extend to younger patients with no medical contraindications to #kidney transplantation who are normally considered prime candidates. https://t.co/MucKWbxuP0
-
-
Mashup Score: 0
“Providers can use this information to counsel patients that that initial sticker shock goes away once you stick with that medication,” says Katherine Shapiro, MD.
Source: www.urologytimes.comCategories: Latest Headlines, UrologyTweet-
Dr. Katherine Shapiro discusses how recent study findings on access and costs of oral medications for overactive bladder will affect her counseling of patients. #urology #urologist #OAB @NYUUrology Watch now: https://t.co/FfVoLzewYM
-
-
Mashup Score: 2Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for Aggressive Prostate Cancer - 2 year(s) ago
This genetic association study examines the association between variants of established prostate cancer risk genes and the risk of aggressive prostate cancer.
Source: jamanetwork.comCategories: Latest Headlines, UrologyTweet-
Results from an exome-sequencing genetic association study in @JAMAOnc showed that known and new deleterious genetic variants in DNA-repair genes are associated with aggressive disease in patients with prostate cancer and might inform disease management https://t.co/O4gwcMtzum
-
-
Mashup Score: 0Abstracts - AUA Annual Meeting - 2 year(s) ago
Abstracts information for AUA2024 in San Antonio, TX.
Source: www.auanet.orgCategories: Latest Headlines, UrologyTweet-
We're counting down to the Abstract submission deadline and we don't want you to miss out! ⌛ Click here for more information or to submit your abstract today ➡️ https://t.co/ioDHLiXJCn #AUA #AUAMembers #Urology #AUA24 https://t.co/cwAYZBxG2P
-
-
Mashup Score: 10
A European group of experts produced the first consensus statements on oligometastatic bladder cancer (OMBC). On the basis of the evidence available, up to three metastatic sites that can be radically resected or irradiated after a favourable response to systemic therapy was proposed as a definition of OMBC. This definition can assist standardisation of future research to provide guidance on patient selection for OMBC management options.
Source: www.europeanurology.comCategories: Latest Headlines, UrologyTweet-
Definition and Diagnosis of Oligometastatic Bladder Cancer: A Delphi Consensus Study Endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary Faculty https://t.co/yffsxU9Vms https://t.co/HS4s9NrRuo
-
-
Mashup Score: 0In conversation with James Green - 2 year(s) ago
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Read our Cookies
Source: www.urologynews.uk.comCategories: Latest Headlines, UrologyTweet-
📚Read James Green @greenxmedical's Interview https://t.co/VRJYpvH1vG https://t.co/9Fb8v2cuo8
-
-
Mashup Score: 1
Positive phase III trials are not truly practice changing if they do not accurately inform on the best options for patients
Source: ascopubs.orgCategories: Latest Headlines, UrologyTweet-
RT @Dr_RaviMadan: https://t.co/b0wpz7z8yf #PARP inhibitors in #ProstateCancer ? https://t.co/zGDkQUb6e9
-
Blue Earth Diagnostics has entered into a partnership with Sinotau Pharmaceutical Group to make its PSMA-PET imaging agent flotufolastat F 18 available for use in patients with #prostatecancer in China. #urology #urologist #pcsm Read more: https://t.co/sOytjUWZxw